Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer? Commentary Journal Article
| Author: | Herr, H. W. |
| Article Title: | Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer? Commentary |
| Keywords: | clinical trial; drug tolerability; placebo; cancer risk; drug withdrawal; treatment duration; adjuvant therapy; cancer staging; drug megadose; outcome assessment; recurrent cancer; antineoplastic agent; cancer grading; cancer prevention; smoking cessation; patient monitoring; bladder cancer; cancer mortality; isoflavone derivative; disease severity; early diagnosis; cyclooxygenase 2 inhibitor; eflornithine; nonsteroid antiinflammatory agent; rofecoxib; endoscopic surgery; short survey; diet therapy; alpha tocopherol; ascorbic acid; selenium; cystoscopy; retinol; transurethral resection; bladder carcinoma; quinoline derived antiinfective agent; atorvastatin; hydroxymethylglutaryl coenzyme a reductase inhibitor; retinoid; hearing loss; vitamin; genistein; pyridoxine; cauterization; isothiocyanic acid derivative; audiography |
| Journal Title: | Nature Clinical Practice Urology |
| Volume: | 4 |
| Issue: | 5 |
| ISSN: | 1743-4270 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2007-05-01 |
| Start Page: | 240 |
| End Page: | 241 |
| Language: | English |
| DOI: | 10.1038/ncpuro0753 |
| PROVIDER: | scopus |
| PUBMED: | 17325729 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 17 November 2011" - "Source: Scopus" |
